All entries for: Stoke Therapeutics

August 3, 2026

Stoke Therapeutics

Neutral Outlook

Bedford, MA
201-500 employees

If these rules or other MFN pricing rules are finalized, they are likely to mandate reduced prices of at least some drugs in the United States, if they are also sold in comparator countries.

March 16, 2026

Stoke Therapeutics

Neutral Outlook

Bedford, MA
201-500 employees

Thus, while it is unclear how the IRA will be implemented, it will likely have a significant impact on the pharmaceutical industry.

Disease Area: Neurological Diseases, Rare Diseases
Drug Type: Biologic
November 4, 2025

Stoke Therapeutics

Neutral Outlook

Bedford, MA
201-500 employees

Thus, while it is unclear how the IRA will be implemented, it will likely have a significant impact on the pharmaceutical industry.

Disease Area: Multiple, Neurological Diseases, Rare Diseases
Drug Type: Biologic
May 13, 2025

Stoke Therapeutics

Neutral Outlook

Bedford, MA
201-500 employees

Thus, while it is unclear how the IRA will be implemented, it will likely have a significant impact on the pharmaceutical industry.

Disease Area: Multiple, Neurological Diseases, Rare Diseases
Drug Type: Biologic
Scroll to Top